It is likely that the novel impacts on DNA repair and the various genetic dependencies we have identified and outlined here concerning CYPA loss and inhibition contribute to the sensitivity to CsA we and others have demonstrated in these distinct cancer types, all of which are commonly linked by a characteristic genomic profile involving elevated RS and a high dependency upon resection-driven HRR. The gene discussed is PPIA; the disease is cancer.